Astellas Pharma, Inc. (ALPMY)
14.35
+0.15
(+1.06%)
USD |
OTCM |
Oct 09, 16:00
Astellas Pharma Price to Book Value : 2.153 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.153 |
| October 08, 2026 | 2.13 |
| October 07, 2026 | 2.136 |
| October 06, 2026 | 2.122 |
| October 05, 2026 | 2.132 |
| October 02, 2026 | 2.148 |
| October 01, 2026 | 2.166 |
| September 30, 2026 | 2.171 |
| September 29, 2026 | 2.220 |
| September 28, 2026 | 2.243 |
| September 25, 2026 | 2.283 |
| September 24, 2026 | 2.232 |
| September 23, 2026 | 2.259 |
| September 22, 2026 | 2.303 |
| September 21, 2026 | 2.282 |
| September 18, 2026 | 2.277 |
| September 17, 2026 | 2.279 |
| September 16, 2026 | 2.215 |
| September 15, 2026 | 2.229 |
| September 14, 2026 | 2.228 |
| September 11, 2026 | 2.184 |
| September 10, 2026 | 2.133 |
| September 09, 2026 | 2.165 |
| September 08, 2026 | 2.204 |
| September 04, 2026 | 2.258 |
| Date | Value |
|---|---|
| September 03, 2026 | 2.321 |
| September 02, 2026 | 2.268 |
| September 01, 2026 | 2.235 |
| August 31, 2026 | 2.217 |
| August 28, 2026 | 2.210 |
| August 27, 2026 | 2.243 |
| August 26, 2026 | 2.253 |
| August 25, 2026 | 2.274 |
| August 24, 2026 | 2.256 |
| August 21, 2026 | 2.256 |
| August 20, 2026 | 2.244 |
| August 19, 2026 | 2.267 |
| August 18, 2026 | 2.163 |
| August 17, 2026 | 2.150 |
| August 14, 2026 | 2.208 |
| August 13, 2026 | 2.181 |
| August 12, 2026 | 2.219 |
| August 11, 2026 | 2.234 |
| August 10, 2026 | 2.234 |
| August 07, 2026 | 2.219 |
| August 06, 2026 | 2.144 |
| August 05, 2026 | 2.118 |
| August 04, 2026 | 2.07 |
| August 03, 2026 | 2.050 |
| July 31, 2026 | 2.060 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.273 |
| Daiichi Sankyo Co., Ltd. | 2.910 |
| Ono Pharmaceutical Co., Ltd. | 1.253 |
| Eisai Co., Ltd. | 1.477 |
| Chugai Pharmaceutical Co., Ltd. | 5.054 |
Price to Book Value Related Metrics
| PE Ratio | 10.94 |
| PS Ratio | 1.753 |
| PEG Ratio | 0.0343 |
| Price to Free Cash Flow | 8.340 |
| Price | 14.35 |
| Earnings Yield | 9.14% |
| Market Cap | 25.73B |
| PEGY Ratio | 0.0343 |
| Operating PE Ratio | 8.057 |
| Normalized PE Ratio | 10.94 |